Gene: HUNK
Official Full Name: hormonally up-regulated Neu-associated kinaseprovided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in intracellular signal transduction. Predicted to act upstream of or within protein phosphorylation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01427 | HUNK Knockout cell line(SW480) | Human | HUNK | 1:2~1:4 | Negative | Online Inquiry |
KO17045 | HUNK Knockout cell line (HeLa) | Human | HUNK | 1:3~1:6 | Negative | Online Inquiry |
KO17046 | HUNK Knockout cell line (HEK293) | Human | HUNK | 1:3~1:6 | Negative | Online Inquiry |
HUNK Gene Knockout Cell Lines are genetically engineered cellular models designed to study the functional implications of the HUNK gene, which encodes a protein involved in crucial cellular processes such as growth and proliferation. These knockout models are created through advanced CRISPR-Cas9 technology, ensuring precise genome editing that disables the HUNK gene, allowing researchers to investigate its role in various biological pathways and diseases.
The primary function of HUNK Gene Knockout Cell Lines is to facilitate the exploration of the HUNK protein's involvement in cellular signaling, development, and oncogenic processes. By comparing the behavior of knockout cells to their wild-type counterparts, scientists can elucidate the gene's influence on processes like cell cycle regulation, apoptosis, and metabolic pathways. This dynamic analysis not only enhances our understanding of HUNK’s biological roles but also opens avenues for discovering potential therapeutic targets in cancer and other disorders associated with cellular dysregulation.
The scientific importance of this product is underscored by its applications in both basic and applied research settings. In academic labs, these cell lines can serve as critical tools for dissecting molecular mechanisms in disease states, contributing to foundational knowledge that informs future therapeutic strategies. Clinically, the insights gained from studying the HUNK gene can lead to the development of innovative treatments targeting malignancies or metabolic disorders where HUNK is implicated.
What sets HUNK Gene Knockout Cell Lines apart from alternative models is their high specificity and reliability. Unlike traditional knockout models that can exhibit off-target effects, our cell lines have undergone rigorous validation to ensure the precise and consistent expression of knockout phenotypes. This reliability allows for reproducible results, addressing a common concern in translational research. Additionally, our expert team provides comprehensive support for experimental design, ensuring that researchers can maximize the utility of these models in their studies.
Investing in HUNK Gene Knockout Cell Lines equips researchers and clinicians with an invaluable resource that enhances their understanding of genetic regulation in health and disease. Our commitment to quality and innovation in developing these models is backed by years of expertise in genetic engineering and cell biology, making our products a trusted choice for advancing scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.